CLH Report For Nonanoic Acid CLH report Proposal for Harmonised Classification and Labelling Based on Regulation (EC) No 1272/2008 (CLP Regulation), Annex VI, Part 2 Substance Name: Nonanoic Acid EC Number: 203-931-2 CAS Number: 112-05-0 Index Number: 607-197-00-8 Contact details for dossier submitter: Umweltbundesamt GMbH on behalf of AT Competent Authority Federal Ministry of Agriculture, Forestry, Environment and Water Management Version number: 2 Date: 22.Dec. 2011 1 CLH Report For Nonanoic Acid 2 CLH Report For Nonanoic Acid CONTENTS Part A. 1 PROPOSAL FOR HARMONISED CLASSIFICATION AND LABELLING ................................................ 6 1.1 SUBSTANCE .................................................................................................................................................... 6 1.2 HARMONISED CLASSIFICATION AND LABELLING PROPOSAL ............................................................................... 6 1.3 PROPOSED HARMONISED CLASSIFICATION AND LABELLING BASED ON CLP REGULATION AND/OR DSD CRITERIA 7 2 BACKGROUND TO THE CLH PROPOSAL ............................................................................................... 11 2.1 HISTORY OF THE PREVIOUS CLASSIFICATION AND LABELLING ......................................................................... 11 2.2 SHORT SUMMARY OF THE SCIENTIFIC JUSTIFICATION FOR THE CLH PROPOSAL ................................................ 12 2.3 CURRENT HARMONISED CLASSIFICATION AND LABELLING .............................................................................. 13 2.3.1 Current classification and labelling in Annex VI, Table 3.1 in the CLP Regulation ............................... 13 2.3.2 Current classification and labelling in Annex VI, Table 3.2 in the CLP Regulation ............................... 13 2.4 CURRENT SELF-CLASSIFICATION AND LABELLING ........................................................................................... 13 2.4.1 Current self-classification and labelling based on the CLP Regulation criteria ..................................... 13 2.4.2 Current self-classification and labelling based on DSD criteria ........................................................... 13 3 JUSTIFICATION THAT ACTION IS NEEDED AT COMMUNITY LEVEL ............................................ 13 Part B. SCIENTIFIC EVALUATION OF THE DATA ...................................................................................................... 14 1 IDENTITY OF THE SUBSTANCE ............................................................................................................... 14 1.1 NAME AND OTHER IDENTIFIERS OF THE SUBSTANCE ........................................................................................ 14 1.2 COMPOSITION OF THE SUBSTANCE ................................................................................................................. 15 1.2.1 Composition of test material ................................................................................................................ 15 1.3 PHYSICO-CHEMICAL PROPERTIES ................................................................................................................... 16 2 MANUFACTURE AND USES ....................................................................................................................... 18 2.1 MANUFACTURE............................................................................................................................................. 18 2.2 IDENTIFIED USES ........................................................................................................................................... 18 3 CLASSIFICATION FOR PHYSICO-CHEMICAL PROPERTIES ............................................................. 19 4 HUMAN HEALTH HAZARD ASSESSMENT.............................................................................................. 19 4.1 TOXICOKINETICS (ABSORPTION, METABOLISM, DISTRIBUTION AND ELIMINATION) ........................................... 19 4.1.1 Non-human information ...................................................................................................................... 19 4.1.2 Human information ............................................................................................................................. 24 4.1.3 Summary and discussion on toxicokinetics ........................................................................................... 24 4.2 ACUTE TOXICITY........................................................................................................................................... 24 4.2.1 Non-human information ...................................................................................................................... 25 4.2.1.1 Acute toxicity: oral .........................................................................................................................................25 4.2.1.2 Acute toxicity: inhalation ................................................................................................................................25 4.2.1.3 Acute toxicity: dermal .....................................................................................................................................26 4.2.1.4 Acute toxicity: other routes .............................................................................................................................26 4.2.2 Human information ............................................................................................................................. 26 4.2.3 Summary and discussion of acute toxicity ............................................................................................ 26 4.2.4 Comparison with criteria ..................................................................................................................... 26 4.2.5 Conclusions on classification and labelling.......................................................................................... 27 4.3 SPECIFIC TARGET ORGAN TOXICITY – SINGLE EXPOSURE (STOT SE) ............................................................... 27 4.4 IRRITATION ................................................................................................................................................... 27 4.4.1 Skin irritation ...................................................................................................................................... 27 3 CLH Report For Nonanoic Acid 4.4.1.1 Non-human information ..................................................................................................................................31 4.4.1.2 Human information .........................................................................................................................................32 4.4.1.3 Threshold for acute dermal irritation ................................................................................................................32 4.4.1.4 Summary and discussion of skin irritation ........................................................................................................35 4.4.1.5 Comparison with criteria .................................................................................................................................35 4.4.1.6 Conclusions on classification and labelling ......................................................................................................35 4.4.2 Eye irritation ....................................................................................................................................... 35 4.4.2.1 Non-human information ..................................................................................................................................35 4.4.2.2 Human information .........................................................................................................................................35 4.4.2.3 Summary and discussion of eye irritation .........................................................................................................36 4.4.2.4 Comparison with criteria .................................................................................................................................36 4.4.2.5 Conclusions on classification and labelling ......................................................................................................36 4.4.3 Respiratory tract irritation .................................................................................................................. 36 4.4.3.1 Non-human information ..................................................................................................................................36 4.4.3.2 Human information .........................................................................................................................................36 4.4.3.3 Local respiratory irritation threshold ................................................................................................................36 4.4.3.4 Summary and discussion of respiratory tract irritation ......................................................................................37 4.4.3.5 Comparison with criteria .................................................................................................................................37 4.4.3.6 Conclusions on classification and labelling ......................................................................................................37